170 related articles for article (PubMed ID: 28927159)
1. Diagnostic value of inflammatory cell infiltrates, tumor stroma percentage and disease-free survival in patients with colorectal cancer.
Jakubowska K; Kisielewski W; Kańczuga-Koda L; Koda M; Famulski W
Oncol Lett; 2017 Sep; 14(3):3869-3877. PubMed ID: 28927159
[TBL] [Abstract][Full Text] [Related]
2. Stromal and intraepithelial tumor-infiltrating lymphocytes in colorectal carcinoma.
Jakubowska K; Kisielewski W; Kańczuga-Koda L; Koda M; Famulski W
Oncol Lett; 2017 Dec; 14(6):6421-6432. PubMed ID: 29151905
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of inflammatory cell response in patients with colorectal cancer.
Jakubowska K; Koda M; Kisielewski W; Kańczuga-Koda L; Famulski W
Oncol Lett; 2019 Jul; 18(1):783-791. PubMed ID: 31289555
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the prognostic value of measures of the tumor inflammatory cell infiltrate and tumor-associated stroma in patients with primary operable colorectal cancer.
Park JH; McMillan DC; Edwards J; Horgan PG; Roxburgh CS
Oncoimmunology; 2016 Mar; 5(3):e1098801. PubMed ID: 27141369
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer.
Park JH; McMillan DC; Powell AG; Richards CH; Horgan PG; Edwards J; Roxburgh CS
Clin Cancer Res; 2015 Feb; 21(4):882-8. PubMed ID: 25473000
[TBL] [Abstract][Full Text] [Related]
6. The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer.
van Wyk HC; Roseweir A; Alexander P; Park JH; Horgan PG; McMillan DC; Edwards J
Ann Surg Oncol; 2019 Dec; 26(13):4397-4404. PubMed ID: 31605345
[TBL] [Abstract][Full Text] [Related]
7. The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
Park JH; Richards CH; McMillan DC; Horgan PG; Roxburgh CSD
Ann Oncol; 2014 Mar; 25(3):644-651. PubMed ID: 24458470
[TBL] [Abstract][Full Text] [Related]
8. The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
van Wyk HC; Park JH; Edwards J; Horgan PG; McMillan DC; Going JJ
Br J Cancer; 2016 Jul; 115(2):156-63. PubMed ID: 27299960
[TBL] [Abstract][Full Text] [Related]
9. Utility of Glasgow Microenvironment Score as a prognostic tool in colorectal carcinoma.
Ahuja M; Dwarak A; Mallya V; Mandal S; Tomar R; Khurana N; Lal P; Singh K
J Cancer Res Ther; 2023 Apr; 19(Supplement):S172-S176. PubMed ID: 37147995
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocytes in primary tumors of colorectal cancer and their metastases.
Jakubowska K; Koda M; Kisielewski W; Kańczuga-Koda L; Famulski W
Exp Ther Med; 2019 Dec; 18(6):4904-4912. PubMed ID: 31807155
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating lymphocytes in tissue material combined with systemic lymphocyte inflammation in patients with colorectal cancer.
Jakubowska K; Koda M; Grudzińska M; Lomperta K; Famulski W
Mol Clin Oncol; 2021 May; 14(5):97. PubMed ID: 33767866
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer.
Waniczek D; Lorenc Z; Śnietura M; Wesecki M; Kopec A; Muc-Wierzgoń M
Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):445-454. PubMed ID: 28343267
[TBL] [Abstract][Full Text] [Related]
15. Comparison of visual and automated assessment of tumour inflammatory infiltrates in patients with colorectal cancer.
Forrest R; Guthrie GJ; Orange C; Horgan PG; McMillan DC; Roxburgh CS
Eur J Cancer; 2014 Feb; 50(3):544-52. PubMed ID: 24332571
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.
Vangangelt KMH; Tollenaar LSA; van Pelt GW; de Kruijf EM; Dekker TJA; Kuppen PJK; Tollenaar RAEM; Mesker WE
Int J Cancer; 2018 Dec; 143(12):3194-3200. PubMed ID: 29978463
[TBL] [Abstract][Full Text] [Related]
17. The clinical utility of the local inflammatory response in colorectal cancer.
Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145
[TBL] [Abstract][Full Text] [Related]
18. The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer.
Richards CH; Flegg KM; Roxburgh CS; Going JJ; Mohammed Z; Horgan PG; McMillan DC
Br J Cancer; 2012 Jun; 106(12):2010-5. PubMed ID: 22596238
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammatory response predicts oncological outcomes in patients undergoing elective surgery for mismatch repair-deficient colorectal cancer.
Climent M; Ryan ÉJ; Stakelum Á; Khaw YL; Creavin B; Lloyd A; Alhassan D; Mohan HM; Kennelly R; Sheahan K; Winter DC
Int J Colorectal Dis; 2019 Jun; 34(6):1069-1078. PubMed ID: 30993458
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE
BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
